• Journal of Microbiology and Biotechnology
• /
• 제18권6호
• /
• pp.1179-1185
• /
• 2008

The immune-stimulating activities of Bordetella bronchiseptica antigens containing dermonecrotoxin (BBD) loaded in chitosan microspheres (CMs) have already been reported in vitro and in vivo with a mouse alveolar macrophage cell line (RAW264.7) and mice. Therefore, this study attempted to demonstrate the successful induction of mucosal immune responses after the intranasal administration of BBD loaded in CMs (BBD-CMs) in colostrum-deprived pigs. The BBD was introduced to the CMs using an ionic gelation process involving tripolyphosphate (TPP). Colostrum-deprived pigs were then directly immunized through intranasal administration of the BBD-CMs. A challenge with a field isolate of B. bronchiseptica was performed ten days following the final immunization. The BBD-specific IgG and IgA titers, evident in the nasal wash and serum from the vaccinated pigs, increased with time (p<0.05). Following the challenge, the clinical signs of infection were about 6-fold lower in the vaccinated pigs compared with the nonvaccinated pigs. The grades for gross morphological changes in the turbinate bones from the vaccinated pigs were also significantly lower than the grades recorded for the nonvaccinated pigs (p<0.001). Therefore, the mucosal and systemic immune responses induced in the current study would seem to indicate that the intranasal administration of BBD-CMs may be an effective vaccine against atrophic rhinitis in pigs.

• 한국자기학회지
• /
• 제16권4호
• /
• pp.221-227
• /
• 2006

균일한 마그나타이트 나노 입자를 합성하기 위해 음향화학법을 이용한 공침 기술을 적용해 합성 하였다. 입자의 크기를 제어하고 응집을 막기 위해 계면활성제로 올레인산을 사용하였다. 이 방법으로 합성한 마그네타이트 나노입자를 의학적으로 이용하기 위해 나노 입자의 표면을 개질하고 자성 미소구체를 제조 하였다. 마그네타이트 입자의 표면 개질과 자성 미소 구체를 제조하기 위해 저독성, 생분해성, 생체 친화성의 특징을 갖고 있는 키토산과 $\beta$-글루칸을 사용하였다. 생체 고분자로 마그네타이트 나노 입자를 피복하기 위해 묽은 초산 용액을 이용하여 키토산을 용해하고 $\beta$-글루칸은 묽은 수산화나트륨에 용해하여 사용 하였다.나노 입자의 피복은 자성유체를 초음파를 가해주면서 용해시킨 각각의 생체 고분자 용액을 서서히 가하여 나노 입자를 피복하였다. 자성 미소구체는 2 % 키토산과 5 %의 $\beta$-글루칸 수용액을 이용해 제조 하였다. 마그네타이트를 생체 고분자에 분산 시켜 주기 위해 콜로이드 상으로 제조 하고 초음파를 조사 해주어 분무 장치를 통해 미소 구체를 제조하였다. SQUID(SuperconductingQuantum Interference Device)를 측정한 결과 피복한 나노 입자와 미소구체에서 모두 초상자성을 나타내고 있었으며 MRI(Magnetic Resonance Imaging) 측정 결과 MRI 조영제와 색전 물질로서 사용하기 적합 하다는 것을 확인 할 수 있었다.

• 한국재료학회:학술대회논문집
• /
• 한국재료학회 2009년도 추계학술발표대회
• /
• pp.42.1-42.1
• /
• 2009

In recent years, it has been tried to develop the efficacy and bioactivity of Calcium Phosphate cements(CPC) as injectable bone substitute (IBS) by reinforcing them through varying the amount in its compositions and relative concentrations or adding other additives. In this study, the biocompatibility of are inforced Calcium Phosphate-Calcium Sulfate injectable bone substitute (IBS)containing poly ($\varepsilon$-caprolactone)PCL microspheres was evaluated which consisted of solution chitosan and Na-citrate as liquid phase and tetra calcium phosphate (TTCP), dicalciumphosphate anhydrous (DCPA) powder as the solid phase. The in vitrobiocompatibility of the IBS was done using MTT assay and Cellular adhesion and spreading studies. The in vitro experiments with simulated body fluid (SBF) confirmed the formation of apatite on sample surface after 7 and 14 days of incubation in SBF. SEM images for one cell morphologies showed that the cellular attachment was good. MG-63 cells were found to maintain their phenotype on samples and SEM micrograph confirmed that cellular attachment was well. In vitro cytotoxicity tests by an extract dilution method showed that the IBS was cytocompatible for fibroblast L-929.

• Nuclear Medicine and Molecular Imaging
• /
• 제40권2호
• /
• pp.127-131
• /
• 2006

Radiosynovectomy has been used as an effective treatment in patients with resistant synovitis after failure of long-term medication and intraarticular steroid injection. Although $^{90}Y$ silicate/citrate, $^{186}Re$ sulfide, and $^{169}Er$ citrate were approved in Europe for the appropriate radiopharmaceuticals for radiosynovectomy other radionuclides such as $^{32}P$-chromic phosphate, $^{165}Dy$-ferric hydroxide macroaggregate, $^{188}Rh$-microspheres, $^{153}Sm-particulate, and $^{166}Ho$-ferric hydroxide macroaggregate have been used in many countries. Reported success rates range from 40% to 90% for the different joints and underlying disease. In Korea, $^{188}Re$-tin-colloid and $^{166}Ho$-chitosan complex are now using as the major radionuclides in radiosynovectomy with good clinical results. A study on radiation synovectomy using $^{188}Re$-tin-colloid for patients with Korean rheumatoid arthritis shows the treatment resulted in the improvement of arthritis and well tolerated in our study, the radiosynovectomy with $^{166}Ho$-chitosan complex in 53 hemophilic patients markedly decreased intra-articular bleeding frequency and need for coagulation factor. This review inculdes general priciples in the application of radiosynovectomy and the clinical experience in Korea.